LapaHope 250 mg Lapatinib I.P. Tablets are an oral targeted therapy prescribed primarily for the treatment of advanced or metastatic HER2-positive breast cancer. It works by inhib…
LapaHope 250 mg Lapatinib I.P. Tablets are an oral targeted therapy prescribed primarily for the treatment of advanced or metastatic HER2-positive breast cancer. It works by inhibiting the intracellular tyrosine kinase domains of both HER2 and EGFR, slowing the growth and multiplication of cancer cells.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Strength 250 mg
Packaging Size 30 Tablets
Pack Size 30 Tablets
Form Tablet
Usage Breast Cancer, HER2+ Breast Ca
Manufactured By Glenmark
Country of Origin Made in India
Composition Lapatinib Tablets IP
Brand Lapahope
Treatment Breast cancer
Minimum order quantity: 50 Bottle
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
